Holen Sie sich die Stockscreener-App
6.97
1.83%
-0.13
Finanzdaten der Immunic Inc-Aktie (IMUX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
6.29%
35.33
|
33.23 | 23.33 | 25.99 | 27.08 |
| Provision For Loan, Lease, And Other Losses |
38.41%
0.209
|
0.151 | 0.341 | 0.048 | 0.055 |
| Depreciation and Amortization |
3.03%
0.034
|
0.033 | 0.042 | 0.04 | 0.043 |
| Operating Income/Loss |
6.29%
-35.33
|
-33.23 | -23.33 | -25.99 | -27.08 |
| Nonoperating Income/Loss |
89.80%
1.228
|
0.647 | 4.027 | 0.414 | 0.263 |
| Net Income/Loss |
4.64%
-34.10
|
-32.59 | -19.30 | -25.58 | -26.82 |
| Basic Average Shares |
41.07%
42.51
|
30.14 | 12.88 | 193.90 | 132.18 |
| Diluted Average Shares |
41.07%
42.51
|
30.14 | 12.88 | 193.90 | 132.18 |
| Basic Earnings Per Share |
25.93%
-0.80
|
-1.08 | -0.07 | -0.13 | -0.20 |
| Diluted Earnings Per Share |
25.93%
-0.80
|
-1.08 | -0.07 | -0.13 | -0.20 |
| Common Stock Dividends |
-
|
- | - | - | - |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):